Suchergebnisse - "Tachibana, Takayoshi"

PubPharm (7)

1

Pre-conditioning intervention in patients with relapsed or refractory acute lymphoblastic leukemia who underwent allogeneic hematopoietic cell transplantation : a KSGCT multicenter retrospective analysis

enthalten in: Annals of hematology | 2021

von Tachibana, T. | Kanda, J. | Ishizaki, T. | +20

2

The SIL index is a simple and objective prognostic indicator in diffuse large B-cell lymphoma

enthalten in: Leukemia & lymphoma | 2016

von Tomita, N. | Suzuki, T. | Miyashita, K. | +19

CommentIn: Leuk Lymphoma. 2016 Dec;57(12 ):2733-2735. - PMID 27686108

3

R-CHOP therapy alone for limited-stage follicular lymphoma

enthalten in: Leukemia research | 2015

von Tomita, N. | Suzuki, T. | Ishiyama, Y. | +17

4

Intrathecal methotrexate prophylaxis and central nervous system relapse in patients with diffuse large B-cell lymphoma following rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone

enthalten in: Leukemia & lymphoma | 2015

von Tomita, N. | Takasaki, H. | Ishiyama, Y. | +17

5

Analysis of outcomes in patients with supra-diaphragmatic vs infra-diaphragmatic diffuse large B cell lymphoma treated with R-CHOP therapy

enthalten in: Leukemia research | 2015

von Nakajima, Y. | Tomita, N. | Itabashi, M. | +17

6

MIB-1 labeling index as a prognostic factor for patients with follicular lymphoma treated with rituximab plus CHOP therapy

enthalten in: Cancer science | 2013

von Yamamoto, E. | Tomita, N. | Sakata, S. | +14

7

Successful selection of chemotherapy based on cell surface antigens in a patient with mixed phenotype acute leukemia

enthalten in: Rinsho ketsueki] The Japanese journal of clinical hematology | 2010

von Takasaki, H. | Tachibana, T. | Tanaka, M. | +3

1
[1]